Stimulation of aniline, p-nitrophenol and N-nitrosodimethylamine metabolism in kidney by pyridine pretreatment of rabbits

被引:13
作者
Arinç, E [1 ]
Adali, O [1 ]
Gençler-Özkan, AM [1 ]
机构
[1] Middle E Tech Univ, Dept Biol Sci, Joint Grad Program Biochem, TR-06531 Ankara, Turkey
关键词
pyridine; kidney; nitrosodimethylamine N-demethylase; p-nitrophenol hydroxylase; aniline; 4-hydroxylase;
D O I
10.1007/s002040000164
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Pyridine has been shown to cause liver and kidney damage in animals and in humans. In a previous study we examined the effects of pyridine on rabbit liver and lung microsomal drug-metabolizing enzymes. In this study, in vivo i.p. administration of pyridine to rabbits caused a significant 3.4-fold increase in kidney N-nitrosodimethylamine (NDMA) N-demethylase activity as compared to the activity in control rabbits. The same treatment also significantly stimulated the activity of other cytochrome P4502E1-associated enzymes. The activities of p-nitrophenol hydroxylase and aniline 4-hydroxylase in kidney microsomes were increased 4.9- and 4.5-fold, respectively. Pyridine treatment increased the P450 content of the kidney 1.6-fold (P < 0.05). SDS-PAGE of both kidney and liver microsomes of pyridine-treated rabbits showed a protein band of enhanced intensity at 51,000 Mr migrating in the region of cytochrome P4502E1. p-Aminophenol, a 4-hydroxylation product of aniline, has been shown to be nephrotoxic and NDMA, a procarcinogen, has been shown to be carcinogenic following bioactivation by NDMA N-demethylase in a number of tissues including the kidney. Since pyridine was shown to be nephrotoxic, it is expected that pyridine potentiates the toxic and/or carcinogenic effects of aniline, p-nitrophenol and NDMA through induction of their metabolism by the cytochrome P450-dependent drug-metabolizing enzymes.
引用
收藏
页码:527 / 532
页数:6
相关论文
共 47 条
[21]  
GUENGERICH FP, 1990, PHARMACOL THERAPEUT, V45, P299
[22]   ENHANCED HEPATIC EXPRESSION OF P450IIE1 FOLLOWING INHALATION EXPOSURE TO PYRIDINE [J].
HOTCHKISS, JA ;
KIM, SG ;
NOVAK, RF ;
DAHL, AR .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1993, 118 (01) :98-104
[23]   PYRIDINE INDUCTION OF SPRAGUE-DAWLEY RAT RENAL CYTOCHROME P4502E1 - IMMUNOHISTOCHEMICAL LOCALIZATION AND QUANTITATION [J].
HOTCHKISS, JA ;
KIM, H ;
HAHN, FF ;
NOVAK, RF ;
DAHL, AR .
TOXICOLOGY LETTERS, 1995, 78 (01) :1-7
[24]   SYNERGISTIC INDUCTION OF RAT MICROSOMAL CYP1A1 AND CYP1A2 BY ACETONE IN COMBINATION WITH PYRIDINE [J].
IBA, MM ;
BENNETT, S ;
STORCH, A ;
GHOSAL, A ;
THOMAS, PE .
CANCER LETTERS, 1993, 74 (1-2) :69-74
[25]   EVIDENCE FOR BIOCHEMICALLY DIFFERENT TYPES OF VESICLES IN HEPATIC MICROSOMAL FRACTION [J].
IMAI, Y ;
ITO, A ;
SATO, R .
JOURNAL OF BIOCHEMISTRY, 1966, 60 (04) :417-+
[26]   MEASUREMENT OF CYTOCHROME-P-450 IN PRESENCE OF LARGE AMOUNTS OF CONTAMINATING HEMOGLOBIN AND METHEMOGLOBIN [J].
JOHANNESEN, KAM ;
DEPIERRE, JW .
ANALYTICAL BIOCHEMISTRY, 1978, 86 (02) :725-732
[27]  
JOHANSSON I, 1988, CANCER RES, V48, P5387
[28]   ECOTOXICOLOGICAL PROFILE OF PYRIDINE [J].
JORI, A ;
CALAMARI, D ;
CATTABENI, F ;
DIDOMENICO, A ;
GALLI, CL ;
GALLI, E ;
SILANO, V .
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 1983, 7 (03) :251-275
[29]  
KALF GF, 1987, ANNU REV PHARMACOL, V27, P399
[30]  
KAUL KL, 1987, J PHARMACOL EXP THER, V243, P384